Related Experiment Video
Updated: Jun 19, 2026

16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Diabetes: an investor's perspective
1Vesalius Ventures, Houston, Texas 77056, USA. bernard@vesaliusventures.com
Journal of Diabetes Science and Technology
|November 4, 2009
Summary
Rising healthcare costs and an aging population present challenges, but technological innovations in telemedicine and health IT offer new solutions for efficient diabetes care delivery.
Area of Science:
- Health Economics
- Medical Technology
- Digital Health
Background:
- Healthcare expenditure reached $2.1 trillion in 2006, with projections to double due to rising chronic disease treatment costs.
- The aging baby boomer demographic is expected to significantly increase the burden on healthcare systems.
- Employer-based health insurance premiums saw annual increases of up to 10% in 2006.
Purpose of the Study:
- To explore investment opportunities in healthcare driven by rising costs and demographic shifts.
- To present a business perspective on leveraging technology for improved healthcare delivery.
- To highlight new technological applications for efficient diabetes patient care.
Main Methods:
- Analysis of healthcare expenditure trends and demographic impacts.
- Review of emerging technologies in telemedicine, health IT, and medical devices.
- Case examples of technology applications for diabetes management.
Main Results:
- Significant growth in healthcare spending is driven by chronic conditions and an aging population.
- Telemedicine, health IT, and medical technology represent key investment areas.
- New technologies enable effective and efficient diabetes care regardless of patient location.
Conclusions:
- Technological innovation is crucial for addressing escalating healthcare costs and demands.
- Strategic investment in health tech can lead to improved patient outcomes, particularly for chronic diseases like diabetes.
- The integration of advanced technologies promises a more accessible and efficient healthcare future.
Related Concept Videos
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
